Hydroxyxanthone as an inhibitor of cAMP-activated apical chloride channel in human intestinal epithelial cell

Life Sciences

Volumn 90, Issue 25-26, 2012, Pages 988-994

  Luerang, Wachiraporn ^a   Khammee, Thongchai ^b   Kumpum, Watinee ^b   Suksamrarn, Sunit ^b   Chatsudthipong, Varanuj ^a   Muanprasat, Chatchai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

Author keywords

CFTR; Cholera; Intestinal chloride secretion; Secretory diarrhea; Xanthone

Indexed keywords

1,3 DIHYDROXYXANTHONE; 1,3,6 TRIHYDROXYXANTHONE; 1,3,6,8 TETRAHYDROXYXANTHONE; 1,3,8 TRIHYDROXYXANTHONE; CATECHOL; CHLORIDE CHANNEL; CHOLERA TOXIN; CYCLIC AMP; DHX 001; SALICYLIC ACID; TETHX 001; THX 001; THX 002; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIARRHEAL ACTIVITY; APICAL MEMBRANE; ARTICLE; CHLORIDE CURRENT; CHOLERA; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ELECTROPHYSIOLOGY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; IMMUNOASSAY; INTESTINE EPITHELIUM; NONHUMAN; OXIDATIVE COUPLING; RAT; SHORT CIRCUIT CURRENT; SYNTHESIS;

ANIMALS; CELLS, CULTURED; CHLORIDE CHANNELS; CYCLIC AMP; EPITHELIAL CELLS; HUMANS; INTESTINAL MUCOSA; MICE; MICE, INBRED ICR; RATS; RATS, INBRED F344; XANTHONES;

RATTUS;

EID: 84863314622     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.05.001     Document Type: Article

References (25)

1. K.E. Barrett, and S.J. Keely Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects Annu Rev Physiol 62 2000 535 572
2. S. Basu, and M.J. Pickett Reaction of Vibrio cholerae and choleragenic toxin in ileal loop of laboratory animals J Bacteriol 100 1969 1142 1143
3. L.S. Capettini, L.V. Campos, M.H. Dos Santos, T.J. Nagem, V.S. Lemos, and S.F. Cortes Vasodilator and antioxidant effect of xanthones isolated from Brazilian medicinal plants Planta Med 75 2009 145 148
4. C.L. Chaignat What about cholera vaccines? Expert Rev Vaccines 7 2008 403 405
5. M. Claeson, and M.H. Merson Global progress in the control of diarrheal diseases Pediatr Infect Dis J 9 1990 345 355
6. H.R. El-Seedi, M.A. El-Barbary, D.M. El-Ghorab, L. Bohlin, A.K. Borg-Karlson, and U. Goransson Recent insights into the biosynthesis and biological activities of natural xanthones Curr Med Chem 17 2010 854 901
7. M. Field Intestinal ion transport and the pathophysiology of diarrhea J Clin Invest 111 2003 931 943
8. M. Field, D. Fromm, Q. al-Awqati, and W.B. Greenough III Effect of cholera enterotoxin on ion transport across isolated ileal mucosa J Clin Invest 51 1972 796 804
9. L.V. Galietta, S. Jayaraman, and A.S. Verkman Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists Am J Physiol Cell Physiol 281 2001 C1734 C1742
10. D.C. Griffith, L.A. Kelly-Hope, and M.A. Miller Review of reported cholera outbreaks worldwide, 1995-2005 Am J Trop Med Hyg 75 2006 973 977
11. K.M. Hoque, O.M. Woodward, D.B. van Rossum, N.C. Zachos, L. Chen, and G.P. Leung Epac1 mediates protein kinase A-independent mechanism of forskolin-activated intestinal chloride secretion J Gen Physiol 135 2010 43 58
12. M.V. Ignatushchenko, R.W. Winter, H.P. Bachinger, D.J. Hinrichs, and M.K. Riscoe Xanthones as antimalarial agents; studies of a possible mode of action FEBS Lett 409 1997 67 73
13. B. Illek, M.E. Lizarzaburu, V. Lee, M.H. Nantz, M.J. Kurth, and H. Fischer Structural determinants for activation and block of CFTR-mediated chloride currents by apigenin Am J Physiol Cell Physiol 279 2000 C1838 C1846
14. Y. Liu, L. Zou, L. Ma, W.H. Chen, B. Wang, and Z.L. Xu Synthesis and pharmacological activities of xanthone derivatives as alpha-glucosidase inhibitors Bioorg Med Chem 14 2006 5683 5690
15. C. Muanprasat, L. Sirianant, S. Soodvilai, R. Chokchaisiri, A. Suksamrarn, and V. Chatsudthipong Novel action of the chalcone isoliquiritigenin as a cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor: potential therapy for cholera and polycystic kidney disease J Pharmacol Sci 118 2012 82 91
16. Y. Na Recent cancer drug development with xanthone structures J Pharm Pharmacol 61 2009 707 712
17. D. Obolskiy, I. Pischel, N. Siriwatanametanon, and M. Heinrich Garcinia mangostana L.: a phytochemical and pharmacological review Phytother Res 23 2009 1047 1065
18. J. Pedraza-Chaverri, N. Cardenas-Rodriguez, M. Orozco-Ibarra, and J.M. Perez-Rojas Medicinal properties of mangosteen (Garcinia mangostana) Food Chem Toxicol 46 2008 3227 3239
19. D.A. Sack, R.B. Sack, G.B. Nair, and A.K. Siddique Cholera Lancet 363 2004 223 233
20. M. Schuier, H. Sies, B. Illek, and H. Fischer Cocoa-related flavonoids inhibit CFTR-mediated chloride transport across T84 human colon epithelia J Nutr 135 2005 2320 2325
21. J.R. Thiagarajah, and A.S. Verkman CFTR pharmacology and its role in intestinal fluid secretion Curr Opin Pharmacol 3 2003 594 599
22. J.R. Thiagarajah, and A.S. Verkman New drug targets for cholera therapy Trends Pharmacol Sci 26 2005 172 175
23. F. Visioli, C.A. De La Lastra, C. Andres-Lacueva, M. Aviram, C. Calhau, and A. Cassano Polyphenols and human health: a prospectus Crit Rev Food Sci Nutr 51 2011 524 546
24. Y. Wang, J.G. Shi, M.Z. Wang, C.T. Che, and J.H. Yeung Mechanisms of the vasorelaxant effect of 1,5-dihydroxy-2,3-dimethoxy-xanthone, an active metabolite of 1-hydroxy-2,3,5-trimethoxy-xanthone isolated from a Tibetan herb, Halenia elliptica, on rat coronary artery Life Sci 82 2008 91 98
25. N. Wongsamitkul, L. Sirianant, C. Muanprasat, and V. Chatsudthipong A plant-derived hydrolysable tannin inhibits CFTR chloride channel: a potential treatment of diarrhea Pharm Res 27 2010 490 497